Global Regenerative Medicine Market Analysis Reveals Promising Value and CAGR of 23.3% until the End of 2021

Published on : Apr 17, 2018

Albany, New York, April 17, 2018: One of the most promising and rapidly developing areas in the treatment of pain is regenerative medicine. It is predicted to become an increasingly common and vital area of medicine in the future, particularly with regard to stem cell sciences. A new research study titled “Global Regenerative Medicine Market Analysis & Forecast to 2021; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries” has been publicized to the vast database of Market Research Hub (MRH), which outlines the current and future trends of the global regenerative medicine market along with a detailed analysis of key factors influencing the market. This is a 680-page industry report that is supported by over 350 tables and figures and has tracked the market over the last decade.

With an extensive forecast to 2021, the study aims to offer market dynamics that influence the current nature and future status of this market. As per the recent analysis, the regenerative medicine market has the massive scope and can be applied to a wide range of diseases and indications including neurological, autoimmune, cardiovascular, diabetes, musculoskeletal, ocular, and orthopedic and wound healing. The analyst has anticipated that the global regenerative medicine market was worth $18.9 billion in 2016 and will grow to over $53.7 billion by 2021, with a notable CAGR of 23.3% between the mentioned time frame.

Geographical analysis

In the initial section, the study presents an overview of regenerative medicine which includes: stem cells, allogenic and autogenic cells, umbilical cord blood banking, tissue engineering and CAR T therapies. Moving further, the report offers global access challenges of the regenerative medicine market, by highlighting some prime regions including North America, Asia-Pacific and Europe, within key topographies including the USA, Japan, South Korea, and China. Through the regional analysis, the research found that the US currently has the biggest space, followed by Europe.

The segmental analysis section of the report highlights individual analysis of the categories covering introduction, clinical trials, drug discovery, products and biomarkers. It has been observed that the stem cell industry will grow significantly at an impressive CAGR until the end of 2021. Apart from that, tissue engineering is forecast to grow rapidly in the coming years. Interestingly, the report also takes a detailed look at the CAR-T industry and its impact on the healthcare space.

In the later section, to assist in proper decision-making, the report includes the profiling of top players in this industry. Key companies profiled in this study include Astellas Institute for Regenerative Medicine (Ocata Therapeutics), Caladrius Biosciences (NeoStem), Athersys, Baxter International (Baxalta, Shire), Cytori Therapeutics, MEDIPOST, Cynata Therapeutics, Pluristem Therapeutics, Osiris Therapeutics, STEMCELL Technologies and others. Each of the players in the market has been analyzed on the basis of their financials, pipeline products and business strategy for the future growth.

Request a Sample with TOC in a PDF format :

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top